The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-2-Amino-N-(1-((5,5'-diallyl-2,2'-dihydroxy-[1,1'-biphenyl]-3-yl)methyl)piperidin-4-yl)-4-(methylthio)butanamide ID: ALA4765116
PubChem CID: 162660838
Max Phase: Preclinical
Molecular Formula: C29H39N3O3S
Molecular Weight: 509.72
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: C=CCc1ccc(O)c(-c2cc(CC=C)cc(CN3CCC(NC(=O)[C@@H](N)CCSC)CC3)c2O)c1
Standard InChI: InChI=1S/C29H39N3O3S/c1-4-6-20-8-9-27(33)24(17-20)25-18-21(7-5-2)16-22(28(25)34)19-32-13-10-23(11-14-32)31-29(35)26(30)12-15-36-3/h4-5,8-9,16-18,23,26,33-34H,1-2,6-7,10-15,19,30H2,3H3,(H,31,35)/t26-/m0/s1
Standard InChI Key: SZZOXHARXINCTP-SANMLTNESA-N
Molfile:
RDKit 2D
36 38 0 0 0 0 0 0 0 0999 V2000
18.0800 -4.7958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0788 -5.6153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7869 -6.0243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4965 -5.6149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4937 -4.7922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7851 -4.3869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2014 -6.0216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2013 -6.8399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9088 -7.2473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6169 -6.8375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6130 -6.0161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9049 -5.6124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2011 -4.3788 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.4929 -7.2474 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.3708 -6.0234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6634 -5.6142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9554 -6.0223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3186 -5.6039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0284 -6.0089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7340 -5.5967 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7826 -3.5698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0737 -3.1633 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.0739 -2.3426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3690 -1.9362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6601 -2.3434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6606 -3.1616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3700 -3.5725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9510 -1.9341 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.2433 -2.3428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5356 -1.9342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2434 -3.1599 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.5355 -1.1170 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.8279 -2.3429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1202 -1.9343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4125 -2.3430 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
11.7048 -1.9345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
4 7 1 0
5 13 1 0
8 14 1 0
2 15 1 0
15 16 1 0
16 17 2 0
11 18 1 0
18 19 1 0
19 20 2 0
6 21 1 0
21 22 1 0
22 23 1 0
22 27 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
25 28 1 0
28 29 1 0
29 30 1 0
29 31 2 0
30 32 1 6
30 33 1 0
33 34 1 0
34 35 1 0
35 36 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 509.72Molecular Weight (Monoisotopic): 509.2712AlogP: 4.38#Rotatable Bonds: 12Polar Surface Area: 98.82Molecular Species: BASEHBA: 6HBD: 4#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 5#RO5 Violations (Lipinski): 1CX Acidic pKa: 7.67CX Basic pKa: 9.47CX LogP: 3.24CX LogD: 1.91Aromatic Rings: 2Heavy Atoms: 36QED Weighted: 0.32Np Likeness Score: 0.04
References 1. Zhao M,Zheng YH,Zhao QY,Zheng W,Yang JH,Pei HY,Liu L,Liu KJ,Xue LL,Deng DX,Wang L,Ma X,Fu SH,Peng AH,Tang MH,Luo YZ,Ye HY,Chen LJ. (2021) Synthesis and evaluation of new compounds bearing 3-(4-aminopiperidin-1-yl)methyl magnolol scaffold as anticancer agents for the treatment of non-small cell lung cancer via targeting autophagy., 209 [PMID:33069436 ] [10.1016/j.ejmech.2020.112922 ]